Sanofi (SNY) Income from Continuing Operations (2009 - 2026)

Sanofi has disclosed Income from Continuing Operations across 18 years of filings, most recently posting $2.2 billion for Q2 2026.

• In Q2 2026, Income from Continuing Operations fell 1.95% year-over-year to $2.2 billion; the TTM figure through Jun 2026 stood at $12.9 billion (down 5.55% YoY), while the FY2025 annual figure was $6.0 billion, down 45.07% from the prior year.
• Income from Continuing Operations came in at $2.2 billion for Q2 2026 at Sanofi, down from $3.3 billion in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of $11.3 billion in Q3 2025 to a low of -$3.8 billion in Q4 2025.
• Average Income from Continuing Operations over 5 years is $3.9 billion, with a median of $3.2 billion recorded in 2022.
• Year-over-year, Income from Continuing Operations jumped 420.75% in 2022 and plunged 220.88% in 2025.
• Over 5 years, Income from Continuing Operations stood at $9.2 billion in 2022, then rose by 10.29% to $10.1 billion in 2023, then slumped by 68.86% to $3.2 billion in 2024, then sank by 220.88% to -$3.8 billion in 2025, then soared by 156.7% to $2.2 billion in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were $2.2 billion in Q2 2026, $3.3 billion in Q1 2026, and -$3.8 billion in Q4 2025.